symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
BSSP,1e-06,0,0,372,0,1.0E-6-1.0E-4,0,"Reve Technologies, Inc.",USD,0001495028,,070249107,Other OTC,PNK,Biotechnology,https://www.cantechpharma.com,"Reve Technologies, Inc., a drug development company, provides advanced therapeutics for the treatment of cancer. It offers irreversible pepsin fraction (IPF), a therapeutic platform technology that is used to facilitate a range of applications. The company's solution is also used for the treatment of autoimmune diseases, such as cirrhosis and Hepatitis C. The company was founded in 2010 and is based in San Clemente, California.",Mr. Dennis R. Alexander,Healthcare,US,,714-907-1241,300 South El Camino Real,San Clemente,CA,92672,,0,https://financialmodelingprep.com/image-stock/BSSP.png,2012-12-13,True,False,True,False,False
